Bay Street News, January 18th, 2024

BELTSVILLE, Md., Jan. 18, 2024 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing […]

WEST FARGO, N.D., Jan. 18, 2024 (GLOBE NEWSWIRE) — Titan Machinery Inc. (NASDAQ:TITN) announced today that it has elected Richard […]

Lyon (France) and Cambridge (MA, US), January 18, 2024, at 10:05pm CET – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), a […]

Davos, Switzerland, Jan. 18, 2024 (GLOBE NEWSWIRE) — SEALSQ Corp (“SEALSQ” or “Company”) (NASDAQ: LAES), a company that focuses on […]

SAN FRANCISCO, Jan. 18, 2024 (GLOBE NEWSWIRE) — All Remote – GitLab Inc., the most comprehensive AI-powered DevSecOps platform, today […]

IK-930 optimized formulation now in the clinic; on track to deliver additional monotherapy data in 2H 2024 IK-595 first cohort […]

PHOENIX, Jan. 18, 2024 (GLOBE NEWSWIRE) —  Leslie’s, Inc. (NASDAQ: LESL), the largest and most trusted direct-to-consumer brand in the […]

– Data demonstrate early activity with casdozokitug/atezolizumab/bevacizumab; 38% objective response rate including three complete responses – – Data support casdozo […]

ATLANTA, GA., Jan. 18, 2024 (GLOBE NEWSWIRE) — Americold Realty Trust, Inc. (NYSE: COLD) (the “Company”), a global leader in […]

– Open label extension (OLE) Phase 2 data show peak efficacy for all ABP-450 doses and cycles in treating cervical […]